|
|
|
CUSIP No. 229790100
|
|
|
Page 7 of 10
|
|
|
Item 1(a). Name of Issuer: Cue Health
Inc. (the Issuer)
Item 1(b). Address of Issuers Principal Executive Officers: 4980 Carroll Canyon Rd., Suite 100, San
Diego, CA 92121
Item 2(a). Name of Person Filing:
KSP Cue Health Investments, LLC (KSP Cue Health)
KSI
Investment Holdings, LLC (KSI Investment)
KSI Equity Holdings, LP (KSI Equity)
KSI Holdings LP, Inc. (KSI Holdings)
Koch
Industries, Inc. (Koch Industries)
(Each a Reporting Person, and collectively, the Reporting Persons).
Item 2(b). Address or Principal Business Office or, if None, Residence:
The principal business office for all Reporting Persons filing is:
4111 E. 37th Street North
Wichita, KS 67220
Item 2(c). Citizenship: See Item
4 of each cover page.
Item 2(d).Title of Class of Securities: Common Stock, par value $0.00001 per share (Public
Shares).
Item 2(e).CUSIP No.: 229790100.
Item 3. If this Statement is Filed Pursuant to §§ 240.13d-1(b) or
240.13d-2(b) or (c), Check Whether the Person Filing is a: Not applicable.
Item 4. Ownership.
(a) Amount beneficially owned: See Item 9 of each cover page.
(b) Percent of class: See Item 11 of each cover page. Calculated using 143,766,583 Public Shares outstanding after the closing of the Issuers
initial public offering, which number of shares was reported as expected to be outstanding in the prospectus dated September 23, 2021 and filed by the Issuer on September 23, 2021 pursuant to Rule 424(b)(4) under the Securities Act of 1933.
(c) Number of shares as to which the person has:
|
(i)
|
Sole power to vote or to direct the vote: See Item 5 of each cover page.
|
|
(ii)
|
Shared power to vote or to direct the vote: See Item 6 of each cover page.
|
|
(iii)
|
Sole power to dispose or to direct the disposition of: See Item 7 of each cover page.
|
|
(iv)
|
Shared power to dispose or to direct the disposition of: See Item 8 of each cover page.
|
KSP Cue Health is 100% owned by KSI Investment. KSI Investment is 100% owned by KSI Equity. KSI Equity is managed by its general partner, KSI Holdings. KSI
Holdings is 100% owned by Koch Industries.
Koch Industries, KSI Holdings, KSI Equity and KSI Investment may be deemed to beneficially own the Public
Shares held by KSP Cue Health by virtue of Koch Industries ownership of KSI Holdings, KSI Holdings serving as general partner of KSI Equity, KSI Equitys ownership of KSI Investment and KSI Investments ownership of KSP Cue Health.
The filing of this Schedule 13G shall not be construed as an admission that any of KSI Investment, KSI Equity, KSI Holdings or Koch Industries is, for purposes of Sections 13(d) or 13(g) of the Exchange Act, the beneficial owner of any
Public Shares covered by this Schedule 13G.